Whitehead Institute researchers used a new approach for analyzing genetic risk data and discovered that disease-linked genes cause problems in brain cells that contribute to multiple sclerosis, which had been thought of as a solely autoimmune disease. This information could lead to the development of new therapies for multiple sclerosis, and the approach can be applied to gain insights into other diseases.